Alpha Core Capital LLC Immunity Bio, Inc. Put Options Transaction History
Alpha Core Capital LLC
- $2.55 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IBRX
# of Institutions
274Shares Held
120MCall Options Held
2.47MPut Options Held
3.13M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.2 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $989M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...